Bakhos Tannous

Company: AstraZeneca

Job title: Head of NeuroOncology Discovery

Seminars:

Luck Meets Design: Serendipitous Molecule Discovery for Targeted Protein Degradation 11:30 am

Developing a drug screening assays to identify novel brain tumor therapies Developing a novel natural compound for targeted protein degradation Application of novel PROTAC for breast and brain cancerRead more

day: Conf Day 2

Panel Discussion – Comparing & Contrasting the Abilities of Phenotypic VS Target Based Screening 1:30 pm

Comparing phenotypic and target-based screening to reveal phenotypic approaches’ broad discovery potential versus the specificity of target-based methods Contrasting these methods to highlight phenotypic screening’s ability to uncover novel mechanisms of action, while target-based screening focuses on predefined molecular targets Discussing both approaches to underscore phenotypic screening’s relevance in identifying hits through functional therapeutic effects, compared to…Read more

day: Conf Day 2